Published in Stroke on October 23, 2003
Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging (2010) 3.03
Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke (2008) 2.57
Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab (2008) 1.86
Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab (2010) 1.68
Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology (2009) 1.59
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Neurology (2009) 1.47
The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab (2012) 1.46
Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke (2012) 1.43
Association between pH-weighted endogenous amide proton chemical exchange saturation transfer MRI and tissue lactic acidosis during acute ischemic stroke. J Cereb Blood Flow Metab (2011) 1.36
Determinants of the distribution and severity of hypoperfusion in patients with ischemic stroke. Neurology (2008) 1.36
Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab (2008) 1.35
Heterogeneity in the penumbra. J Cereb Blood Flow Metab (2011) 1.33
Early experience of translating pH-weighted MRI to image human subjects at 3 Tesla. Stroke (2010) 1.25
MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab (2009) 1.20
Spatiotemporal dynamics of diffusional kurtosis, mean diffusivity and perfusion changes in experimental stroke. Brain Res (2012) 1.20
Quantitative prediction of ischemic stroke tissue fate. NMR Biomed (2008) 1.12
Imaging of acute stroke. Nat Rev Neurol (2010) 1.09
Direct visualization of mouse brain oxygen distribution by electron paramagnetic resonance imaging: application to focal cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.08
Correlation of volumetric mismatch and mismatch of Alberta Stroke Program Early CT Scores on CT perfusion maps. Neuroradiology (2008) 1.08
Refining the mismatch concept in acute stroke: lessons learned from PET and MRI. J Cereb Blood Flow Metab (2012) 1.07
Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Stroke (2009) 1.01
Probing ischemic tissue fate with BOLD fMRI of brief oxygen challenge. Brain Res (2011) 1.01
Quantitative temporal profiles of penumbra and infarction during permanent middle cerebral artery occlusion in rats. Transl Stroke Res (2010) 0.98
Artificial neural network prediction of ischemic tissue fate in acute stroke imaging. J Cereb Blood Flow Metab (2010) 0.96
Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution. Brain Res (2005) 0.95
Quantitative prediction of acute ischemic tissue fate using support vector machine. Brain Res (2011) 0.94
Simultaneous and noninvasive imaging of cerebral oxygen metabolic rate, blood flow and oxygen extraction fraction in stroke mice. Neuroimage (2012) 0.93
Effects of cerebral ischemic and reperfusion on T2*-weighted MRI responses to brief oxygen challenge. J Cereb Blood Flow Metab (2013) 0.92
Diffusion-perfusion mismatch: an opportunity for improvement in cortical function. Front Neurol (2015) 0.91
Current diagnosis and management of symptomatic intracranial atherosclerotic disease. Curr Opin Neurol (2012) 0.91
Imaging stroke patients with unclear onset times. Neuroimaging Clin N Am (2011) 0.90
Serial MR analysis of early permanent and transient ischemia in rats: diffusion tensor imaging and high b value diffusion weighted imaging. Korean J Radiol (2013) 0.89
Validation of fast diffusion kurtosis MRI for imaging acute ischemia in a rodent model of stroke. NMR Biomed (2014) 0.89
Imaging of acute ischemic stroke. Neuroimaging Clin N Am (2010) 0.89
Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol (2009) 0.89
Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent. Stroke (2011) 0.88
Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update. Front Neurol (2014) 0.88
Diffusion tensor and perfusion MRI of non-human primates. Methods (2009) 0.88
Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol (2013) 0.88
Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update. World J Radiol (2012) 0.87
Spatiotemporal dynamic simulation of acute perfusion/diffusion ischemic stroke lesions evolution: a pilot study derived from longitudinal MR patient data. Comput Math Methods Med (2013) 0.86
Vessel size imaging reveals pathological changes of microvessel density and size in acute ischemia. J Cereb Blood Flow Metab (2011) 0.84
Efficacy and safety of endovascular treatment versus intravenous thrombolysis for acute ischemic stroke: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.84
Modelling of pH dynamics in brain cells after stroke. Interface Focus (2011) 0.84
Early identification of potentially salvageable tissue with MRI-based predictive algorithms after experimental ischemic stroke. J Cereb Blood Flow Metab (2013) 0.84
Characterizing cerebral oxygen metabolism employing oxygen-17 MRI/MRS at high fields. MAGMA (2013) 0.83
In vivo imaging of induction of heat-shock protein-70 gene expression with fluorescence reflectance imaging and intravital confocal microscopy following brain ischaemia in reporter mice. Eur J Nucl Med Mol Imaging (2012) 0.83
The effects of delayed reduction of tonic inhibition on ischemic lesion and sensorimotor function. J Cereb Blood Flow Metab (2015) 0.82
Unexpected recovery of function after severe traumatic brain injury: the limits of early neuroimaging-based outcome prediction. Neurocrit Care (2013) 0.82
The association between neurological deficit in acute ischemic stroke and mean transit time: comparison of four different perfusion MRI algorithms. Neuroradiology (2005) 0.82
Multiparametric magnetic resonance imaging of brain disorders. Top Magn Reson Imaging (2010) 0.81
Early metabolic changes following ischemia onset in rats: an in vivo diffusion-weighted imaging and 1H-magnetic resonance spectroscopy study at 7.0 T. Mol Med Rep (2015) 0.81
Inhomogeneous sodium accumulation in the ischemic core in rat focal cerebral ischemia by 23Na MRI. J Magn Reson Imaging (2009) 0.81
Arterial spin labeling for acute stroke: practical considerations. Transl Stroke Res (2012) 0.80
Real-time ultrasound brain perfusion imaging with analysis of microbubble replenishment in acute MCA stroke. J Cereb Blood Flow Metab (2011) 0.80
MRI of perfusion-diffusion mismatch in non-human primate (baboon) stroke: a preliminary report. Open Neuroimag J (2011) 0.80
Reperfusion therapies for acute ischemic stroke: an update. Curr Cardiol Rev (2014) 0.79
Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset. Neuroradiology (2013) 0.79
Arterial spin-labeled perfusion imaging in acute ischemic stroke. Stroke (2014) 0.79
Stability of ischemic core volume during the initial hours of acute large vessel ischemic stroke in a subgroup of mechanically revascularized patients. Neuroradiology (2014) 0.79
Precise Characterization of the Penumbra Revealed by MRI: A Modified Photothrombotic Stroke Model Study. PLoS One (2016) 0.79
Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol (2016) 0.79
(129) Xe chemical shift in human blood and pulmonary blood oxygenation measurement in humans using hyperpolarized (129) Xe NMR. Magn Reson Med (2016) 0.79
Imaging Oxygen Metabolism In Acute Stroke Using MRI. Curr Radiol Rep (2014) 0.78
Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep (2004) 0.78
Neuroimaging of cerebral ischemia and infarction. Neurotherapeutics (2011) 0.78
Blood-oxygenation-level-dependent-(BOLD-) based R2' MRI study in monkey model of reversible middle cerebral artery occlusion. J Biomed Biotechnol (2011) 0.78
Partial-volume effect on ischemic tissue-fate delineation using quantitative perfusion and diffusion imaging on a rat stroke model. Magn Reson Med (2004) 0.78
Multimodal MRI of experimental stroke. Transl Stroke Res (2011) 0.78
Assessment of baseline hemodynamic parameters within infarct progression areas in acute stroke patients using perfusion-weighted MRI. Neuroradiology (2010) 0.77
Incorporating ADC temporal profiles to predict ischemic tissue fate in acute stroke. Brain Res (2012) 0.77
The Continued Promise of Neuroprotection for Acute Stroke Treatment. J Exp Stroke Transl Med (2008) 0.77
Neurogenic neuroprotection: clinical perspectives. Funct Neurol (2013) 0.77
Altered resting-state FMRI signals in acute stroke patients with ischemic penumbra. PLoS One (2014) 0.76
Effects of stroke severity and treatment duration in normobaric hyperoxia treatment of ischemic stroke. Brain Res (2016) 0.76
A review of current imaging methods used in stroke research. Neurol Res (2013) 0.76
Modelling of the physiological response of the brain to ischaemic stroke. Interface Focus (2013) 0.76
Current concepts on magnetic resonance imaging (MRI) perfusion-diffusion assessment in acute ischaemic stroke: a review & an update for the clinicians. Indian J Med Res (2014) 0.76
Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Stroke (2009) 0.76
Erythropoietin reduces apoptosis of brain tissue cells in rats after cerebral ischemia/reperfusion injury: a characteristic analysis using magnetic resonance imaging. Neural Regen Res (2016) 0.76
Impact of reperfusion after 3 hours of symptom onset on tissue fate in acute cerebral ischemia. J Neuroimaging (2008) 0.75
Impact of Slow Blood Filling via Collaterals on Infarct Growth: Comparison of Mismatch and Collateral Status. J Stroke (2016) 0.75
Recent MRI advances in experimental stroke. Transl Stroke Res (2012) 0.75
Magnetic resonance characterization of ischemic tissue metabolism. Open Neuroimag J (2011) 0.75
Fast diffusion kurtosis imaging (DKI) with Inherent COrrelation-based Normalization (ICON) enhances automatic segmentation of heterogeneous diffusion MRI lesion in acute stroke. NMR Biomed (2016) 0.75
Successful outcome after endovascular thrombolysis for acute ischemic stroke with basis on perfusion-diffusion mismatch after 24 h of symptoms onset. Surg Neurol Int (2016) 0.75
Comparison of magnetic resonance imaging mismatch criteria to select patients for endovascular stroke therapy. Stroke (2014) 0.75
Novel gradient echo sequence‑based amide proton transfer magnetic resonance imaging in hyperacute cerebral infarction. Mol Med Rep (2015) 0.75
Magnetic resonance imaging of perfusion-diffusion mismatch in rodent and non-human primate stroke models. Neurol Res (2013) 0.75
Improving the detection sensitivity of pH-weighted amide proton transfer MRI in acute stroke patients using extrapolated semisolid magnetization transfer reference signals. Magn Reson Med (2017) 0.75
Benchmarking transverse spin relaxation based oxygenation measurements in the brain during hypercapnia and hypoxia. J Magn Reson Imaging (2017) 0.75
Mapping of cerebral metabolic rate of oxygen using dynamic susceptibility contrast and blood oxygen level dependent MR imaging in acute ischemic stroke. Neuroradiology (2015) 0.75
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med (2002) 3.18
Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
The smoking-thrombolysis paradox and acute ischemic stroke. Neurology (2005) 2.31
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke (2011) 2.23
Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke (2010) 2.17
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06
Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ (2012) 2.04
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02
Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med (2008) 2.00
Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke (2009) 1.96
Diffusion tensor imaging demonstrates brainstem and cerebellar abnormalities in congenital central hypoventilation syndrome. Pediatr Res (2008) 1.86
A midlife stroke surge among women in the United States. Neurology (2007) 1.86
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke (2014) 1.76
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71
Expanding indications for statins in cerebral ischemia: a quantitative study. Arch Neurol (2005) 1.69
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation (2010) 1.66
Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke (2009) 1.63
Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis (2003) 1.60
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59
Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med (2012) 1.55
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes (2012) 1.54
Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54
Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol (2007) 1.53
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magn Reson Med (2007) 1.53
Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation (2011) 1.51
Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc (2012) 1.48
Does achieving an intensive versus usual blood pressure level prevent stroke? Ann Neurol (2011) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Risk of intracranial hemorrhage with protease-activated receptor-1 antagonists. Stroke (2012) 1.44
Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke (2012) 1.43
The new standing guideline committee policy of the American Stroke Association Stroke Council. Stroke (2006) 1.42
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke (2012) 1.41
Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke (2010) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke (2012) 1.40
Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40
Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke (2009) 1.38
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis (2008) 1.37
Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke (2005) 1.37
Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis (2008) 1.37
Evidence of publication bias in reporting acute stroke clinical trials. Neurology (2006) 1.37
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke (2010) 1.35
The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care (2003) 1.35
Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep (2008) 1.34
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes (2013) 1.31
Reduced white matter integrity in attention-deficit hyperactivity disorder. Neuroreport (2008) 1.31
Brain responses associated with the Valsalva maneuver revealed by functional magnetic resonance imaging. J Neurophysiol (2002) 1.28
Therapeutic milestone: stroke declines from the second to the third leading organ- and disease-specific cause of death in the United States. Stroke (2010) 1.28
In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke (2004) 1.28
Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Stroke (2010) 1.28
Early nonischemic oxidative metabolic dysfunction leads to chronic brain atrophy in traumatic brain injury. J Cereb Blood Flow Metab (2009) 1.28